Refined management and risk control in the use of oxytocin in delivery rooms

JIN Zhi-shan; ZHAO Yin

doi:10.19538/j.fk2026040102

PDF(960 KB)

Chinese Journal of Practical Gynecology and Obstetrics ›› 2026, Vol. 42 ›› Issue (4) : 389-395. DOI: 10.19538/j.fk2026040102

Refined management and risk control in the use of oxytocin in delivery rooms

JIN Zhi-shan ¹ ,
ZHAO Yin ¹^,²

Author information +

History +

Abstract

Oxytocin plays a crucial role in the process of labor induction and augmentation by promoting uterine contractions. However，its administration requires refined management to ensure maternal and fetal safety and to avoid uterine tachysystole and related complications. This article systematically reviews the physiological and pharmacological mechanisms of oxytocin， clinical outcomes of different administration protocols， monitoring techniques， risk factors and corresponding control strategies. Incorporating the latest randomized controlled trials and observational studies，it focuses on the clinical value of oxytocin dose adjustment，timing of use，individualized management，and multidisciplinary collaboration in reducing cesarean section rates and preventing uterine rupture and postpartum hemorrhage. Through a comprehensive analysis of existing evidence，this paper aims to provide evidence-based guidance for clinical obstetric practice，promote the safe and effective use of oxytocin，optimize delivery room management protocols，and improve maternal and neonatal health outcomes.

Key words

oxytocin / delivery room management / risk control / cesarean section / uterine rupture / postpartum hemorrhage

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

JIN Zhi-shan , ZHAO Yin. Refined management and risk control in the use of oxytocin in delivery rooms[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2026, 42(4): 389-395 https://doi.org/10.19538/j.fk2026040102

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

[1]	Dale HH. On some physiological actions of ergot[J]. J Physiol, 1906, 34(3):163-206. DOI:10.1113/jphysiol.1906.sp001148. Cited in this article [1]

[2]	Du Vigneaud V, Ressler C, Trippett S. The sequence of amino acids in oxytocin,with a proposal for the structure of oxytocin[J]. J Biol Chem, 1953, 205(2):949-957. Cited in this article [1]

[3]	Uvnäs-Moberg K. The physiology and pharmacology of oxytocin in labor and in the peripartum period[J]. Am J Obstet Gynecol, 2024, 230(3S):S740-S758. DOI:10.1016/j.ajog.2023.04.011. Cited in this article [3]

[4]	Hermesch AC, Kernberg AS, Layoun VR, et al. Oxytocin: physiology, pharmacology,and clinical application for labor management[J]. Am J Obstet Gynecol, 2024, 230(3S):S729-S739. DOI:10.1016/j.ajog.2023.06.041. Cited in this article [4]

[5]	Maejima Y, Yokota S, Yamachi M, et al. Oxytocin enhances demethylation through tet enzyme expression in neurons of aged mice: oxytocin as a potential antiaging peptide[J]. Aging Cell, 2025, 24(10):e70198. DOI:10.1111/acel.70198. Cited in this article [1]

[6]	Heydenreich FM, Plouffe B, Rizk A, et al. Michaelis-menten quantification of ligand signaling bias applied to the promiscuous vasopressin V2 receptor[J]. Mol Pharmacol, 2022, 102(3):139-149. DOI:10.1124/molpharm.122.000497. Cited in this article [1]

[7]

Bekkenes

, Jørgensen

, Jacobsen

, et al. Effects of prophylactic oxytocin or carbetocin on troponin release and postpartum haemorrhage at planned caesarean delivery: a double-blind randomised controlled trial[J]. BJOG, 2025, 132(12):1742-1752. DOI:10.1111/1471-0528.18312.

Cited in this article [1]

[8]	Reddy UM, Sandoval GJ, Tita ATN, et al. Oxytocin regimen used for induction of labor and pregnancy outcomes[J]. Am J Obstet Gynecol MFM, 2024, 6(12):101508. DOI:10.1016/j.ajogmf.2024.101508. Cited in this article [3]

[9]	Wheeler V, Hoffman A, Bybel M. Cervical ripening and induction of labor[J]. Am Fam Physician, 2022, 105(2):177-186. Cited in this article [1]

[10]	Dubay R, Rentschler N, Jolly D, et al. Does adjunctive oxytocin infusion during balloon cervical ripening improve labor induction?[J]. J Fam Pract, 2022, 71(2):E18-E19. DOI:10.12788/jfp.0353. Cited in this article [2]

[11]	Wu XL, Liu HY, Xiang QH, et al. Double balloon combined with oxytocin in labor induction: analysis of multivariate factors affecting the efficacy of cervical ripening[J]. Int J Womens Health, 2024, 16:1219-1227. DOI:10.2147/IJWH.S460853. Cited in this article [1]

[12]	Gagnon J, Corlin T, Berghella V, et al. Intracervical Foley catheter with and without oxytocin for labor induction with Bishop score ≤3: a secondary analysis[J]. Am J Obstet Gynecol MFM, 2021, 3(4):100350. DOI:10.1016/j.ajogmf.2021.100350. Cited in this article [1]

[13]

Nkobetchou

, Ray

, Girault

. Oral misoprostol versus vaginal dinoprostone for term labor induction among women requiring oxytocin before 4 cm: A secondary analysis of the STOPOXY trial[J]. Eur J Obstet Gynecol Reprod Biol, 2026, 316:114809. DOI:10.1016/j.ejogrb.2025.114809.

Cited in this article [1]

[14]	Gulersen M, DiSturco M, Krantz DA, et al. Comparison of two management options for labor induction following unsuccessful prostaglandin E2 ripening[J]. J Matern Fetal Neonatal Med, 2022, 35(9):1759-1763. DOI:10.1080/14767058.2020.1769594. Cited in this article [1]

[15]	中华医学会妇产科学分会产科学组. 妊娠晚期促子宫颈成熟与引产指南(2024)[J]. 中华妇产科杂志, 2024, 59(11): 819-828. DOI:10.3760/cma.j.cn112141-20240707-00381. Cited in this article [2]

[16]	ACOG. First and Second Stage Labor Management: ACOG Clinical Practice Guideline No. 8[J]. Obstet Gynecol, 2024, 143(1):144-162. DOI:10.1097/AOG.0000000000005447. Cited in this article [1]

[17]	Logue TC, Zullo F, van Biema F, et al. High- vs low-dose oxytocin regimens for labor augmentation: a systematic review and meta-analysis[J]. Am J Obstet Gynecol MFM, 2025, 7(2):101604. DOI:10.1016/j.ajogmf.2025.101604. Cited in this article [3]

[18]	Grasch JL, Costantine MM, Cahill AG, et al. High- vs low-dose oxytocin protocols for labor induction: a systematic review and meta-analysis[J]. Am J Obstet Gynecol MFM, 2025, 7(7):101691. DOI:10.1016/j.ajogmf.2025.101691. Cited in this article [1]

[19]	Aboshama RA, Abdelhakim AM, Shareef MA, et al. High dose vs. low dose oxytocin for labor augmentation: a systematic review and meta-analysis of randomized controlled trials[J]. J Perinat Med, 2020; 49(2):178-190. DOI:10.1515/jpm-2020-0042. Cited in this article [1]

[20]	Moraes FCA, Kelly FA, Leite MGHSJ, et al. High-dose versus low-dose oxytocin for labor augmentation: a meta-analysis of randomized controlled trials[J]. J Pers Med, 2024, 14(7):724. DOI:10.3390/jpm14070724. Cited in this article [1]

[21]	Nunes I, Dupont C. European Guidelines on Perinatal Care - Oxytocin for induction and augmentation of labor[J]. J Matern Fetal Neonatal Med, 2022, 35(25):7166-7172. DOI:10.1080/14767058.2021.1945577. Cited in this article [4]

[22]	Adams AD, Coviello EM, Drassinower D. The effect of maternal obesity on oxytocin requirements to achieve vaginal delivery[J]. Am J Perinatol, 2020, 37(4):349-356. DOI:10.1055/s-0039-1694982. Cited in this article [1]

[23]	Wei RM, Bounthavong M, Hill MG. High- vs low-dose oxytocin in lean and obese women: a double-blinded randomized controlled trial[J]. Am J Obstet Gynecol MFM, 2022, 4(4):100627. DOI:10.1016/j.ajogmf.2022.100627. Cited in this article [1]

[24]	Tadesse T, Assefa N, Roba HS, et al. Failed induction of labor and associated factors among women undergoing induction at University of Gondar Specialized Hospital,Northwest Ethiopia[J]. BMC Pregnancy Childbirth, 2022, 22(1):175. DOI:10.1186/s12884-022-04476-7. Cited in this article [1]

[25]	Mundle S, Lightly K, Durocher J, et al. Oral misoprostol alone,compared with oral misoprostol followed by oxytocin,in women induced for hypertension of pregnancy: A multicentre randomised trial[J]. BJOG, 2024, 131(11):1532-1544. DOI:10.1111/1471-0528.17839. Cited in this article [1]

[26]	Camille O, Laura M, Mona M, et al. Comparison of oxytocin use between singleton and twin pregnancies during induction of labor: A multicenter case-control study[J]. Eur J Obstet Gynecol Reprod Biol, 2025, 306:25-28. DOI:10.1016/j.ejogrb.2024.12.045. Cited in this article [1]

[27]	邹馨逸, 李闯, 魏军. 双胎妊娠的孕期管理与分娩[J]. 中国实用妇科与产科杂志, 2025, 41(2):133-138. DOI:10.19538/j.fk2025020102. Cited in this article [1]

[28]	陈功立, 漆洪波. 产后出血的个体化处理[J]. 中国实用妇科与产科杂志, 2026, 42(1):40-43. DOI:10.19538/j.fk2026010110. Cited in this article [1]

[29]	王媛, 王谢桐. 产后出血的止血方法研究现状[J]. 中国实用妇科与产科杂志, 2024, 40(4):410-412. DOI:10.19538/j.fk2024040108. Cited in this article [1]

[30]	Boujenah J, Renassia S, Djafer R, et al. Effects of a policy for reasonable use of oxytocin during spontaneous labor at term[J]. Gynecol Obstet Fertil Senol, 2020, 48(9):657-664. DOI:10.1016/j.gofs.2020.03.018. Cited in this article [1]

[31]

Jafar

, Hassan

, Usama

, et al. Continued versus discontinued oxytocin in the active phase of induced labor in term pregnancies: an updated systematic review and meta-analysis of randomized controlled trials[J]. Gynecol Obstet Invest, 2026, 91(1):137-147. DOI:10.1159/000546438.

Cited in this article [1]

[32]	Didier-Mathon H, Kayem G, Thubert T, et al. Risk factors for complete uterine rupture in patients with trial of labor after cesarean delivery[J]. Acta Obstet Gynecol Scand, 2025, 104(2):380-388. DOI:10.1111/aogs.15017. Cited in this article [2]

[33]

Secchi

, Albéric

, Gobillot

, et al. Balloon catheter vs oxytocin alone for induction of labor in women with one previous cesarean section and an unfavorable cervix: a multicenter,retrospective study[J]. Arch Gynecol Obstet, 2022, 306(2):379-387. DOI:10.1007/s00404-021-06298-y.

Cited in this article [1]

[34]	Nicolì P, Gulersen M, Beacham J, et al. Oxytocin dosing during trial of labor after cesarean to minimize the risk of uterine rupture: a systematic review and meta-analysis[J]. Am J Obstet Gynecol MFM, 2026, 8(1):101846. DOI:10.1016/j.ajogmf.2025.101846. Cited in this article [2]

[35]	Zhu H, Lu D, Branch DW, et al. Oxytocin is not associated with postpartum hemorrhage in labor augmentation in a retrospective cohort study in the United States[J]. Am J Obstet Gynecol, 2024; 230(2):247.e1-247.e9. DOI:10.1016/j.ajog.2023.07.054. Cited in this article [1]

[36]	张盼盼, 周玮. 产程中子宫收缩的监测[J]. 中国实用妇科与产科杂志, 2024, 40(2):147-150. DOI:10.19538/j.fk2024020105. Cited in this article [1]

[37]	李磊, 王谢桐. 从临床救治再谈产科重症监护病房建设[J]. 中国实用妇科与产科杂志, 2024, 40(10):974-978. DOI:10.19538/j.fk2024100104. Cited in this article [1]

[38]	Vuelta-Arce M, Chiapella-Micó C, Mestre-Prad MT, et al. Comprehensive tackling to the safe handling of hazardous drugs: a multidisciplinary approach to clinical practice[J]. Int J Occup Med Environ Health, 2020, 33(5):621-634. DOI:10.13075/ijomeh.1896.01534. Cited in this article [1]

[39]	Qian X, Zhou B, Li P, Garfield RE, Liu H. Quantitative analysis for grading uterine electromyography activities during labor.[J] Am J Obstet Gynecol MFM, 2023, 5(2):100798. DOI:10.1016/j.ajogmf.2022.100798. Cited in this article [1]